Clinuvel Pharmaceuticals Ltd
ASX:CUV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
AU |
|
Cemindo Gemilang Tbk PT
IDX:CMNT
|
ID |
|
Kri-Kri Milk Industry SA
F:AO2
|
GR |
|
F
|
FMS Enterprises Migun Ltd
OTC:FTCFF
|
IL |
|
Citizen Watch Co Ltd
F:CTZ
|
JP |
|
T
|
Toyobo Co Ltd
F:TO7
|
JP |
|
DBS Group Holdings Ltd
F:DEVL
|
SG |
|
Marui Group Co Ltd
F:MUI
|
JP |
|
I
|
Imperial Pacific Ltd
ASX:IPC
|
AU |
|
Chemed Corp
F:CXM
|
US |
|
Domino's Pizza Enterprises Ltd
ASX:DMP
|
AU |
|
Revive Therapeutics Ltd
F:31R
|
CA |
|
M
|
Matsui Securities Co Ltd
XMUN:MTW
|
JP |
|
C
|
Citizen Watch Co Ltd
OTC:CHCLY
|
JP |
|
T
|
Toyota Tsusho Corp
F:9TO
|
JP |
|
Telefonaktiebolaget LM Ericsson
F:ERCA
|
SE |
|
Kubota Corp
TSE:6326
|
JP |
|
Nusa Palapa Gemilang Tbk PT
IDX:NPGF
|
ID |
|
S
|
Sociedad Quimica y Minera de Chile SA
F:QYM
|
CL |
Dividends
Dividend Yield
Clinuvel Pharmaceuticals Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Clinuvel Pharmaceuticals Ltd
CUV have increased by 100%.
Payout Ratio
Clinuvel Pharmaceuticals Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for CUV is
hidden
.
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
CUV Price
Clinuvel Pharmaceuticals Ltd
| Average Annual Return | -21.74% |
| Standard Deviation of Annual Returns | 16.04% |
| Max Drawdown | -82% |
| Market Capitalization | 383.8m AUD |
| Shares Outstanding | 50 430 000 |
| Percentage of Shares Shorted |
N/A
|
CUV Return Decomposition
Main factors of price return
Stock Splits
CUV's latest stock split occurred on Nov 11, 2010
The company executed a 1-for-10 stock split, meaning that for every 10 shares held, investors received 1 new share.
The adjusted shares began trading on Nov 11, 2010. This was stock split number 2 in CUV's history, following the previous one in Oct 5, 2006.